{
    "clinical_study": {
        "@rank": "112530", 
        "arm_group": [
            {
                "arm_group_label": "Cangrelor IV + Ticagrelor 180mg at 0.5 hr", 
                "arm_group_type": "Experimental", 
                "description": "On Day 1:  Open-label cangrelor IV bolus (30 \u00b5g/kg), followed by an infusion of 4 \u00b5g/kg/min for two hours.  Ticagrelor (180 mg) was administered at 0.5 h after the initiation of cangrelor infusion."
            }, 
            {
                "arm_group_label": "Cangrelor IV + Ticagrelor 90mg  (7 doses)", 
                "arm_group_type": "Experimental", 
                "description": "On Day 1:  Following completion of cangrelor and ticagrelor dosing, patients were discharged and instructed to take 90 mg ticagrelor every 12 hours for 7 doses (12, 24, 36, 48, 60, 72, and 84 h).\nOn Day 5: 12 h post last ticagrelor dose (90 mg), patients received another open-label cangrelor IV bolus (30 \u00b5g/kg), followed by an infusion of 4 \u00b5g/kg/min for two hours."
            }, 
            {
                "arm_group_label": "Cangrelor IV + Ticagrelor 180mg at 1.5 hr", 
                "arm_group_type": "Experimental", 
                "description": "On Day 1:  Open-label cangrelor IV bolus (30 \u00b5g/kg), followed by an infusion of 4 \u00b5g/kg/min for two hours.  Ticagrelor (180 mg) was administered at 1.5 h after the initiation of cangrelor infusion."
            }, 
            {
                "arm_group_label": "Cangrelor IV + Ticagrelor 90mg  (6 doses)", 
                "arm_group_type": "Experimental", 
                "description": "On Day 1:  Following completion of cangrelor and ticagrelor dosing, patients were discharged and instructed to take 90 mg ticagrelor every 12 hours for 6 doses (12, 24, 36, 48, 60, and 72 h).\nOn Day 5: 24 h post last ticagrelor dose (90 mg), patients received another open-label cangrelor IV bolus (30 \u00b5g/kg), followed by an infusion of 4 \u00b5g/kg/min for two hours."
            }
        ], 
        "brief_summary": {
            "textblock": "To demonstrate that patients treated with cangrelor can be directly switched to oral\n      ticagrelor and that patients treated with ticagrelor can be switched to cangrelor without a\n      significant decrease in the extent of  inhibition of platelet aggregation."
        }, 
        "brief_title": "Cangrelor Ticagrelor Transition Study", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "On Day 1:  Open-label cangrelor IV bolus (30 \u00b5g/kg), followed by an infusion of 4 \u00b5g/kg/min for two hours.  Ticagrelor (180 mg) was administered at 0.5 h or 1.5 h after the initiation of cangrelor infusion.  Patients were discharged and instructed to take 90 mg ticagrelor every 12 hours for 6 doses.\nOn Day 5:  Cangrelor was administered after ticagrelor (90 mg)was discontinued 24 hours prior.", 
                            "title": "ITT Population - Ticagrelor 6 Doses"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "On Day 1:  Open-label cangrelor IV bolus (30 \u00b5g/kg), followed by an infusion of 4 \u00b5g/kg/min for two hours.  Ticagrelor (180 mg) was administered at 0.5 h or 1.5 h after the initiation of cangrelor infusion.  Patients were discharged and instructed to take 90 mg ticagrelor every 12 hours for 7 doses.\nOn Day 5:  Cangrelor was administered after ticagrelor (90 mg)was discontinued 12 hours prior.", 
                            "title": "ITT Population - Ticagrelor 7 Doses"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "6"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "6"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "12"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "7.17", 
                                                "@value": "66.3"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "4.32", 
                                                "@value": "66.5"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "5.65", 
                                                "@value": "66.4"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "6"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "6"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "12"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "6"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "6"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "12"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "United States"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study."
            }, 
            "limitations_and_caveats": "None", 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "A reference point was chosen for comparison and designated the first draw during the cangrelor infusion (0.5 hours or 1.25 hours) as the reference for the effect of cangrelor and designated the final draw on study Day 1 (5.25 hours, or 3.25 hours after cangrelor had been discontinued) as the reference for the effect of ticagrelor.  Residual platelet reactivity (the extent of aggregation in the presence or absence of the study drugs) was examined for each of the endpoints using light transmittance aggregometry. Residual platelet reactivity (PR) was measured in response to  20 \u00b5mol adenosine diphosphate (ADP) at 300 seconds (final/terminal aggregation response).", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "title": "All Patients"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Cangrelor was administered as IV infusion for 2 hours.", 
                                    "title": "Cangrelor + Ticagrelor 180mg at 1.25 h of Cangrelor Infusion"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Cangrelor was administered as IV infusion for 2 hours.", 
                                    "title": "Cangrelor + Ticagrelor 180mg at 0.5 h of Cangrelor Infusion"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.7", 
                                                            "@value": "1.7"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "2.0", 
                                                            "@value": "1.3"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.5", 
                                                            "@value": "2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Reference 0.5/1.25 hours - PR"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.4", 
                                                            "@value": "2.2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.8", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.0", 
                                                            "@value": "2.3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "1.75 hours - PR"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "2.2", 
                                                            "@value": "2.3"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.9", 
                                                            "@value": "1.2"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.9", 
                                                            "@value": "3.5"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "2.0 hours - PR"
                                            }
                                        ]
                                    }, 
                                    "description": "A reference point was chosen for comparison and designated the first draw during the cangrelor infusion (0.5 hours or 1.25 hours) as the reference for the effect of cangrelor and designated the final draw on study Day 1 (5.25 hours, or 3.25 hours after cangrelor had been discontinued) as the reference for the effect of ticagrelor.  Residual platelet reactivity (the extent of aggregation in the presence or absence of the study drugs) was examined for each of the endpoints using light transmittance aggregometry. Residual platelet reactivity (PR) was measured in response to  20 \u00b5mol adenosine diphosphate (ADP) at 300 seconds (final/terminal aggregation response).", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Extent of Preservation of Inhibitory Effect Compared With Effect Observed With Cangrelor Alone (at Timepoint 1, Either at 0.5 Hours or 1.25 Hours) or Ticagrelor Alone (Measured 5.25 Hours After Initiation of Cangrelor on Day 1)", 
                                    "units": "percentage of platelet reactivity (PR)"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Day 1 measures taken at 2 timepoints after cangrelor infusion start:  0.5 or 1.5 hrs (Timepoint 1) and 5.25 hrs (TImepoint 2)", 
                        "title": "Extent of Preservation of Inhibitory Effect Compared With Effect Observed With Cangrelor Alone (at Timepoint 1, Either at 0.5 Hours or 1.25 Hours) or Ticagrelor Alone (Measured 5.25 Hours After Initiation of Cangrelor on Day 1)", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "A reference point was chosen for comparison and designated the first draw during the cangrelor infusion (0.5 hours or 1.25 hours) as the reference for the effect of cangrelor.\nResidual platelet reactivity (the extent of aggregation in the presence or absence of the study drugs) was examined for each of the endpoints using light transmittance aggregometry (LTA). Residual platelet reactivity (PR) was measured in response to  20 \u00b5mol ADP at 300 seconds (final/terminal aggregation response).", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "title": "All Patients"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "title": "Ticagrelor Discontinued 24 h Prior to Cangrelor Infusion"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "title": "Ticagrelor Discontinued 12 h Prior to Cangrelor Infusion"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.5", 
                                                            "@value": "1.5"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.6", 
                                                            "@value": "1.5"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.5", 
                                                            "@value": "1.5"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "1.0 hours - PR"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "1.6", 
                                                            "@value": "1.3"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.5", 
                                                            "@value": "1.2"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "1.9", 
                                                            "@value": "1.5"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "2.0 hours - PR"
                                            }
                                        ]
                                    }, 
                                    "description": "A reference point was chosen for comparison and designated the first draw during the cangrelor infusion (0.5 hours or 1.25 hours) as the reference for the effect of cangrelor.\nResidual platelet reactivity (the extent of aggregation in the presence or absence of the study drugs) was examined for each of the endpoints using light transmittance aggregometry (LTA). Residual platelet reactivity (PR) was measured in response to  20 \u00b5mol ADP at 300 seconds (final/terminal aggregation response).", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Extent of Preservation of Inhibitory Effect Compared With Effect Observed During Cangrelor Treatment After Ticagrelor", 
                                    "units": "percentage of platelet reactivity (PR)"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Day 5 at 1.0 and 2.0 hours after the initiation of cangrelor infusion", 
                        "title": "Extent of Preservation of Inhibitory Effect Compared With Effect Observed During Cangrelor Treatment After Ticagrelor", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Blood samples were taken for platelet function studies to conduct pharmacodynamic assessments including LTA.\nA reference point was chosen for comparison and designated the first draw during the cangrelor infusion (0.5 hours or 1.25 hours) as the reference for the effect of cangrelor and designated the final draw on study Day 1 (5.25 hours, or 3.25 hours after cangrelor had been discontinued) as the reference for the effect of ticagrelor.\nResidual platelet reactivity (PR) (the extent of aggregation in the presence or absence of the study drugs) was examined for each of the endpoints using light transmittance aggregometry. Residual platelet reactivity was measured in response to  20 \u00b5mol ADP at 300 seconds (final/terminal aggregation response).", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "title": "All Patients"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Cangrelor was administered as IV infusion for 2 hours.", 
                                    "title": "Cangrelor + Ticagrelor 180mg at 1.25 h of Cangrelor Infusion"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Cangrelor was administered as IV infusion for 2 hours.", 
                                    "title": "Cangrelor + Ticagrelor 180mg at 0.5 h of Cangrelor Infusion"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "3.4", 
                                                            "@value": "4"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "2.7", 
                                                            "@value": "2.2"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "3.1", 
                                                            "@value": "5.8"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Reference 5.25 hours - PR"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "11", 
                                                            "@value": "12"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "12", 
                                                            "@value": "11"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "9.3", 
                                                            "@value": "13"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "2.25 hours - PR"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "16", 
                                                            "@value": "19"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "17", 
                                                            "@value": "21"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "15", 
                                                            "@value": "16"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "2.5 hours - PR"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "9.2", 
                                                            "@value": "10"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "7.2", 
                                                            "@value": "7.8"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "11", 
                                                            "@value": "12"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "2.75 hours - PR"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "6.3", 
                                                            "@value": "7.1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "3.4", 
                                                            "@value": "4.5"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "7.6", 
                                                            "@value": "10"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "3 hours - PR"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "3.6", 
                                                            "@value": "4.6"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "1.9", 
                                                            "@value": "2.5"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "3.7", 
                                                            "@value": "6.7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "4 hours - PR"
                                            }
                                        ]
                                    }, 
                                    "description": "Blood samples were taken for platelet function studies to conduct pharmacodynamic assessments including LTA.\nA reference point was chosen for comparison and designated the first draw during the cangrelor infusion (0.5 hours or 1.25 hours) as the reference for the effect of cangrelor and designated the final draw on study Day 1 (5.25 hours, or 3.25 hours after cangrelor had been discontinued) as the reference for the effect of ticagrelor.\nResidual platelet reactivity (PR) (the extent of aggregation in the presence or absence of the study drugs) was examined for each of the endpoints using light transmittance aggregometry. Residual platelet reactivity was measured in response to  20 \u00b5mol ADP at 300 seconds (final/terminal aggregation response).", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Extent of Aggregation Response During Ticagrelor Treatment", 
                                    "units": "percentage of platelet reactivity  (PR)"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Day 1 at 2.25, 2.5, 2.75, 3 and 4 hrs following initiation of cangrelor infusion", 
                        "title": "Extent of Aggregation Response During Ticagrelor Treatment", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Cangrelor IV (2h) + oral ticagrelor (180mg) administered at 0.5h after the initiation of the cangrelor infusion.", 
                            "title": "Day 1 - Cangrelor + Ticagrelor (180mg) at 0.5h"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Ticagrelor (90mg) discontinued 24h prior to the initiation of a 2h cangrelor infusion.", 
                            "title": "Day 5 - Ticagrelor (90 mg) Dosing (6 Doses)"
                        }, 
                        {
                            "@group_id": "P3", 
                            "description": "Cangrelor IV (2h) + oral ticagrelor (180mg) administered at 1.5h after the initiation of the cangrelor infusion.", 
                            "title": "Day 1 - Cangrelor + Ticagrelor (180mg) at 1.5h"
                        }, 
                        {
                            "@group_id": "P4", 
                            "description": "Ticagrelor (90mg) discontinued 12h prior to the initiation of a 2h cangrelor infusion.", 
                            "title": "Day 5 - Ticagrelor (90mg) Dosing (7 Doses)"
                        }
                    ]
                }, 
                "period_list": {
                    "period": [
                        {
                            "milestone_list": {
                                "milestone": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "6", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "6", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P4"
                                                }
                                            ]
                                        }, 
                                        "title": "STARTED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "6", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "6", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P4"
                                                }
                                            ]
                                        }, 
                                        "title": "COMPLETED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P4"
                                                }
                                            ]
                                        }, 
                                        "title": "NOT COMPLETED"
                                    }
                                ]
                            }, 
                            "title": "Day 1"
                        }, 
                        {
                            "milestone_list": {
                                "milestone": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "6", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "6", 
                                                    "@group_id": "P4"
                                                }
                                            ]
                                        }, 
                                        "title": "STARTED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "6", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "6", 
                                                    "@group_id": "P4"
                                                }
                                            ]
                                        }, 
                                        "title": "COMPLETED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P3"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P4"
                                                }
                                            ]
                                        }, 
                                        "title": "NOT COMPLETED"
                                    }
                                ]
                            }, 
                            "title": "Day 5"
                        }
                    ]
                }, 
                "pre_assignment_details": "Patients with coronary artery disease who were taking aspirin, but not P2Y12 inhibition were enrolled.", 
                "recruitment_details": "The purpose of this study was to study the pharmacodynamic characteristics of transition from IV cangrelor to oral ticagrelor, and ticagrelor to cangrelor in patients with coronary artery disease. This was a single-center study, conducted in Jan-Feb 2013."
            }, 
            "point_of_contact": {
                "email": "jayne.prats@themedco.com", 
                "name_or_title": "Jayne Prats, PhD - VP, Global Knowledge Management", 
                "organization": "The Medicines Company", 
                "phone": "888.779.MDCO ext 1510"
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Ticagrelor was discontinued 24 h prior to cangrelor infusion", 
                            "title": "Cangrelor + Ticagrelor 90mg (6 Doses)"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Ticagrelor discontinued 12 h prior to cangrelor infusion", 
                            "title": "Cangrelor + Ticagrelor 90mg (7 Doses)"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "6"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "6"
                                            }
                                        ], 
                                        "sub_title": "Edema peripheral"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "6"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "6"
                                            }
                                        ], 
                                        "sub_title": "Dyspnea"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }
                        ]
                    }, 
                    "frequency_threshold": "0"
                }
            }
        }, 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  greater than / equal to 18 and less than 75 years of age\n\n               1. Previous myocardial infarction defined by admission to the hospital with\n                  elevation of markers of injury or the presence of pathologic q waves on at least\n                  2 contiguous electrocardiogram (ECG) leads.\n\n                  OR\n\n               2. Previous revascularization by percutaneous coronary intervention (PCI) or\n                  coronary artery bypass graft (CABG) surgery.\n\n                  AND\n\n               3. Treatment with aspirin (ASA) 81 mg daily.\n\n                  Exclusion Criteria:"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 7, 2013", 
        "firstreceived_results_date": "April 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01766466", 
            "org_study_id": "MDCO-CAN-12-03"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Cangrelor IV + Ticagrelor 180mg at 0.5 hr", 
                    "Cangrelor IV + Ticagrelor 90mg  (7 doses)", 
                    "Cangrelor IV + Ticagrelor 180mg at 1.5 hr", 
                    "Cangrelor IV + Ticagrelor 90mg  (6 doses)"
                ], 
                "description": "Open-label cangrelor IV bolus (30 \u00b5g/kg), followed by an infusion of 4 \u00b5g/kg/min for two hours.", 
                "intervention_name": "cangrelor", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Cangrelor IV + Ticagrelor 180mg at 0.5 hr", 
                    "Cangrelor IV + Ticagrelor 90mg  (7 doses)", 
                    "Cangrelor IV + Ticagrelor 180mg at 1.5 hr", 
                    "Cangrelor IV + Ticagrelor 90mg  (6 doses)"
                ], 
                "description": "Ticagrelor 180mg dose:  administered 0.5 h or 1.5h after the initiation of cangrelor infusion\nTicagrelor 90mg:  6 or 7 doses (depending on study arm) taken every 12 hours post cangrelor infusion.", 
                "intervention_name": "Ticagrelor", 
                "intervention_type": "Drug", 
                "other_name": "Brilinta"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cangrelor", 
                "Ticagrelor"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 18, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Burlington", 
                    "country": "United States", 
                    "state": "Vermont", 
                    "zip": "05401"
                }, 
                "name": "Fletcher Allen Health Care"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Study of the Transition From Cangrelor to Ticagrelor, and Ticagrelor to Cangrelor in Patients With Coronary Artery Disease", 
        "overall_official": {
            "affiliation": "Fletcher Allen Health Care", 
            "last_name": "David J. Schneider, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "A reference point was chosen for comparison and designated the first draw during the cangrelor infusion (0.5 hours or 1.25 hours) as the reference for the effect of cangrelor and designated the final draw on study Day 1 (5.25 hours, or 3.25 hours after cangrelor had been discontinued) as the reference for the effect of ticagrelor.  Residual platelet reactivity (the extent of aggregation in the presence or absence of the study drugs) was examined for each of the endpoints using light transmittance aggregometry. Residual platelet reactivity (PR) was measured in response to  20 \u00b5mol adenosine diphosphate (ADP) at 300 seconds (final/terminal aggregation response).", 
                "measure": "Extent of Preservation of Inhibitory Effect Compared With Effect Observed With Cangrelor Alone (at Timepoint 1, Either at 0.5 Hours or 1.25 Hours) or Ticagrelor Alone (Measured 5.25 Hours After Initiation of Cangrelor on Day 1)", 
                "safety_issue": "No", 
                "time_frame": "Day 1 measures taken at 2 timepoints after cangrelor infusion start:  0.5 or 1.5 hrs (Timepoint 1) and 5.25 hrs (TImepoint 2)"
            }, 
            {
                "description": "A reference point was chosen for comparison and designated the first draw during the cangrelor infusion (0.5 hours or 1.25 hours) as the reference for the effect of cangrelor.\nResidual platelet reactivity (the extent of aggregation in the presence or absence of the study drugs) was examined for each of the endpoints using light transmittance aggregometry (LTA). Residual platelet reactivity (PR) was measured in response to  20 \u00b5mol ADP at 300 seconds (final/terminal aggregation response).", 
                "measure": "Extent of Preservation of Inhibitory Effect Compared With Effect Observed During Cangrelor Treatment After Ticagrelor", 
                "safety_issue": "No", 
                "time_frame": "Day 5 at 1.0 and 2.0 hours after the initiation of cangrelor infusion"
            }, 
            {
                "description": "Blood samples were taken for platelet function studies to conduct pharmacodynamic assessments including LTA.\nA reference point was chosen for comparison and designated the first draw during the cangrelor infusion (0.5 hours or 1.25 hours) as the reference for the effect of cangrelor and designated the final draw on study Day 1 (5.25 hours, or 3.25 hours after cangrelor had been discontinued) as the reference for the effect of ticagrelor.\nResidual platelet reactivity (PR) (the extent of aggregation in the presence or absence of the study drugs) was examined for each of the endpoints using light transmittance aggregometry. Residual platelet reactivity was measured in response to  20 \u00b5mol ADP at 300 seconds (final/terminal aggregation response).", 
                "measure": "Extent of Aggregation Response During Ticagrelor Treatment", 
                "safety_issue": "No", 
                "time_frame": "Day 1 at 2.25, 2.5, 2.75, 3 and 4 hrs following initiation of cangrelor infusion"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01766466"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "The Medicines Company", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Medicines Company", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Factorial Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}